Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NUE vs GSK✓SelectedUSD · GSKNUE vs GSK performance historyLatest closeAs of-3.16%11/20
Stock and ETF performance explorer

NUE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+396.4%
GSK return
+97.4%
Excess return
+299.0%
Maximum drawdown
-57.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.2%-0.1%-3.0%-3.1%
7D-4.8%-5.3%+0.5%-3.0%
30D-9.4%-3.7%-5.8%-8.4%
3M-0.1%-7.3%+7.1%+2.2%
6M+6.7%-4.2%+10.9%+7.6%
YTD+48.1%+0.9%+47.3%+45.8%
1Y+64.7%+7.3%+57.4%+58.4%
3Y+59.1%+52.7%+6.4%+27.2%
5Y+128.4%+40.1%+88.2%+85.7%
All+396.4%+97.4%+299.0%+268.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling